Moreover, endothelial YAP/TAZ knockdown or MnCl2 treatment delayed atherogenesis, indicating that YAP/TAZ could become a potential therapeutic target against atherosclerosis [42]. The gene discussed is WWTR1; the disease is atherosclerosis.